Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Andrews

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Transplantation|December 25, 2010
Medications to reduce cardiovascular risk after kidney transplantationPauline A Swift, Peter A Andrews
Transplantation|February 28, 2008
HLA matching: still important despite modern immunosuppressionJames E Marsh, Peter A Andrews
Transplantation|January 23, 2014
Summary of the British Transplantation Society guidelines for transplantation from donors after deceased circulatory deathPeter A Andrews, Lisa Burnapp, Derek Manas, et al.
Clinical Kidney Journal|April 17, 2015
Renal parenchymal calcification secondary to systemic AA amyloidosisHannah M M Burton, Peter A Andrews
Journal of the Royal Society of Medicine|June 4, 2002
Renal vasculitis associated with renal cell carcinomaMark Lloyd, John de Verteuil, Peter A Andrews
Transplantation|October 18, 2011
Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ TransplantationPeter A Andrews, Vincent C Emery, Chas Newstead
Transplantation|March 30, 2012
Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantationPeter A Andrews, Lisa Burnapp, Derek Manas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2002
Outcome of renal allografts from non-heart-beating donors with delayed graft functionClemens Gerstenkorn, David Deardon, C Geoffrey Koffman, et al.
Ophthalmology|March 17, 2004
Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritisConor C Murphy, William H Ayliffe, Anthony Booth, et al.
BMC Nephrology|March 13, 2020
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipientsMysore K Phanish, Richard P Hull, Peter A Andrews, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Transplantation|December 25, 2010
Medications to reduce cardiovascular risk after kidney transplantationPauline A Swift, Peter A Andrews
Transplantation|February 28, 2008
HLA matching: still important despite modern immunosuppressionJames E Marsh, Peter A Andrews
Transplantation|January 23, 2014
Summary of the British Transplantation Society guidelines for transplantation from donors after deceased circulatory deathPeter A Andrews, Lisa Burnapp, Derek Manas, et al.
Clinical Kidney Journal|April 17, 2015
Renal parenchymal calcification secondary to systemic AA amyloidosisHannah M M Burton, Peter A Andrews
Journal of the Royal Society of Medicine|June 4, 2002
Renal vasculitis associated with renal cell carcinomaMark Lloyd, John de Verteuil, Peter A Andrews
Transplantation|October 18, 2011
Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ TransplantationPeter A Andrews, Vincent C Emery, Chas Newstead
Transplantation|March 30, 2012
Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantationPeter A Andrews, Lisa Burnapp, Derek Manas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2002
Outcome of renal allografts from non-heart-beating donors with delayed graft functionClemens Gerstenkorn, David Deardon, C Geoffrey Koffman, et al.
Ophthalmology|March 17, 2004
Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritisConor C Murphy, William H Ayliffe, Anthony Booth, et al.
BMC Nephrology|March 13, 2020
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipientsMysore K Phanish, Richard P Hull, Peter A Andrews, et al.
Pageof 3